MariLisa Dubbelaar
TOF mass spectrometry-based immunopeptidomics refines tumor antigen identification.
Hoenisch Gravel N, Nelde A, Bauer J, Mühlenbruch L, Schroeder S, Neidert M, Scheid J, Lemke S, Dubbelaar M, Wacker M, Dengler A, Klein R, Mauz P, Löwenheim H, Hauri-Hohl M, Martin R, Hennenlotter J, Stenzl A, Heitmann J, Salih H, Rammensee H, Walz J. TOF mass spectrometry-based immunopeptidomics refines tumor antigen identification. Nat Commun 2023; 14:7472.
17.11.2023TOF mass spectrometry-based immunopeptidomics refines tumor antigen identification.
17.11.2023Nat Commun 2023; 14:7472
Hoenisch Gravel Naomi, Nelde Annika, Bauer Jens, Mühlenbruch Lena, Schroeder Sarah M, Neidert Marian Christoph, Scheid Jonas, Lemke Steffen, Dubbelaar MariLisa, Wacker Marcel, Dengler Anna, Klein Reinhild, Mauz Paul-Stefan, Löwenheim Hubert, Hauri-Hohl Mathias, Martin Roland, Hennenlotter Jörg, Stenzl Arnulf, Heitmann Jonas S, Salih Helmut Rainer, Rammensee Hans-Georg, Walz Juliane Sarah
A T-cell antigen atlas for meningioma: novel options for immunotherapy.
Medici G, Freudenmann L, Velz J, Wang S, Kapolou K, Paramasivam N, Mühlenbruch L, Kowalewski D, Vasella F, Bilich T, Frey B, Dubbelaar M, Patterson A, Zeitlberger A, Silginer M, Roth P, Weiss T, Wirsching H, Krayenbühl N, Bozinov O, Regli L, Rammensee H, Rushing E, Sahm F, Walz J, Weller M, Neidert M. A T-cell antigen atlas for meningioma: novel options for immunotherapy. Acta Neuropathol 2023; 146:173-190.
27.06.2023A T-cell antigen atlas for meningioma: novel options for immunotherapy.
27.06.2023Acta Neuropathol 2023; 146:173-190
Medici Gioele, Freudenmann Lena Katharina, Velz Julia, Wang Sophie Shih-Yüng, Kapolou Konstantina, Paramasivam Nagarajan, Mühlenbruch Lena, Kowalewski Daniel Johannes, Vasella Flavio, Bilich Tatjana, Frey Beat M, Dubbelaar MariLisa, Patterson Angelica Brooke, Zeitlberger Anna Maria, Silginer Manuela, Roth Patrick, Weiss Tobias, Wirsching Hans-Georg, Krayenbühl Niklaus, Bozinov Oliver, Regli Luca, Rammensee Hans-Georg, Rushing Elisabeth Jane, Sahm Felix, Walz Juliane Sarah, Weller Michael, Neidert Marian Christoph
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Berner F, Niederer R, Luimstra J, Pop O, Jochum A, Purde M, Hasan Ali O, Bomze D, Bauer J, Freudenmann L, Marcu A, Wolfschmitt E, Haen S, Gross T, Dubbelaar M, Abdou M, Baumgaertner P, Appenzeller C, Cicin-Sain C, Lenz T, Speiser D, Ludewig B, Driessen C, Jörger M, Früh M, Jochum W, Cozzio A, Rammensee H, Walz J, Neefjes J, Flatz L. Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival. Oncoimmunology 2021; 10:2006893.
27.11.2021Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
27.11.2021Oncoimmunology 2021; 10:2006893
Berner Fiamma, Niederer Rebekka, Luimstra Jolien J, Pop Oltin Tiberiu, Jochum Ann-Kristin, Purde Mette-Triin, Hasan Ali Omar, Bomze David, Bauer Jens, Freudenmann Lena Katharina, Marcu Ana, Wolfschmitt Eva-Maria, Haen Sebastian, Gross Thorben, Dubbelaar MariLisa, Abdou Marie-Therese, Baumgaertner Petra, Appenzeller Christina, Cicin-Sain Caroline, Lenz Tobias, Speiser Daniel E, Ludewig Burkhard, Driessen Christoph, Jörger Markus, Früh Martin, Jochum Wolfram, Cozzio Antonio, Rammensee Hans-Georg, Walz Juliane, Neefjes Jacques, Flatz Lukas